Introduction
Healthy People 2000, with its Midcourse Revisions, presents 319 objectives to improve the health of Americans by the year 2000 (1, 2) . Because these objectives are national, not solely Federal, the achievement of these objectives is dependent in part on the ability of health agencies at all levels of government to assess objective progress. To permit comparison of local and State health data with national data and that of other States and localities, Healthy People 2000 objective 22.3 targets the development, dissemination, and use of collection methods that improve comparability among data collected by all levels of government. The objective states:
Develop and disseminate among Federal, State, and local agencies procedures for collecting comparable data for each of the year 2000 national health objectives and incorporate these into Public Health Service data collection systems.
Achieving this objective entails determining and defining the information needed to measure progress toward each national health objective. The purpose of this Statistical Note is to provide definitions and data collection specifications that are used at the national level for objectives in Priority Area 20: Immunization and Infectious Diseases, one of 22 priority areas of Healthy People 2000. In this publication the text (appendix A) and operational definitions of the objectives are presented, important data issues are discussed, and references are cited for expanded discussions of the data systems (appendix B) that provide data for the national objectives. When appropriate, the text of questionnaire items used to measure the objectives is also provided. Table 1 is a data comparability worktable with objective definitions, data sources and issues. This table presents the short text of each objective, the measure, the operational definition (numerator and denominator where applicable), national data source, and a brief description of data issues. The data issues for each objective are discussed in greater detail below. 
Epidemic-related
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Data are calculated by NCID using data from NVSS. These data will be unavailable after 1996. The estimated number of epidemic-related pneumonia and influenza deaths among people 65 years and over involves several steps. The deaths attributable to pneumonia and influenza are identified using ICD-9 codes 480-487. A cyclical regression model (4), based on pneumonia-and influenza-related death rates from previous years, is used to predict the average expected pneumonia-and influenza-related deaths for a given year (the baseline). Periods of increased mortality due to influenza epidemics are excluded from baseline calculations. Epidemic-related deaths are the number of influenza deaths that exceed the baseline by 1.645 standard deviations (4). These deaths are tallied on a weekly basis and totaled annually, starting July 1st and ending June 30th, to encompass the peak flu season in the winter months. Further, the measure used for this objective is the mean of 3 consecutive years divided by the U.S. Census mid-season population of the middle year in the denominator (i.e., the population estimate of January 1, 1995 for people 65 years and over would be used for the 3-year average of the 1993-1994, 1994-1995, and 1995-1996 seasons). The statistic is reported as a rate (deaths per 100,000 population). The National Center for Infectious Diseases (NCID), CDC, calculates this statistic based on data obtained from the National Vital Statistics System (NVSS) of the National Center for Health Statistics (NCHS), CDC.
Viral hepatitis cases
Each year vaccine efficacy rates fluctuate, the strains of influenza viruses differ, and the virulency of those strains fluctuates, making trends in this statistic difficult to track, predict, and compare.
Objective 20.3: Viral hepatitis cases
Viral hepatitis cases are categorized into types A, B, and C, as described in the case definition of the disease (3). The measure for each type of hepatitis is the estimated annual number of cases per 100,000 population, as reported to 6) . The use of these correction factors reflect the results of studies comparing the level of reporting between active and passive surveillance systems, which have found substantial underreporting of viral hepatitis (6) . Hepatitis B cases among special high risk populations are reported as number of cases among injection drug users, heterosexually active people, homosexual men, children of Asians and/or Pacific Islanders, and occupationally-exposed workers, and number of new chronic infections among infants and Alaska Natives. Hepatitis B cases in black people are measured as a rate (cases per 100,000 population). Baseline data for hepatitis B subobjectives have been revised by NCID to take into account various adjustments, including underreporting and estimates of the distribution of various risk factors for hepatitis infection (7). Hepatitis A is tracked as a rate (cases per 100,000 population) for Hispanics and American Indian/Alaska Natives. Hepatitis C is tracked as a rate (cases per 100,000 population) for Hispanics.
Objective 20.4: Tuberculosis incidence
The tuberculosis (TB) incidence rate is calculated by dividing the number of new cases reported to CDC in a year by the mid-year U.S. Bureau of the Census population estimate for that year. The data, published in ''Reported Tuberculosis in the United States,'' are reported as the number of new cases per 100,000 population (8) . Between 1992 and 1995, there was a 14.5-percent decline in the number of TB cases being reported to the tuberculosis surveillance system. This decline in reported TB cases is attributed to improvements in TB control and prevention efforts in the United States.
Objective 20.5: Surgical wound and nosocomial infections
The measure of nosocomial infections for objective 20.5 is the device-associated nosocomial infection rate, reported as infections per 1,000 device days in intensive care units (ICUs). The nosocomial infection rate is reported by the National Nosocomial Infections Surveillance (NNIS) System by ICU category: coronary, medical, medical/surgical, surgical, and pediatric (9) . The NNIS Semiannual Report details the methods used to determine the device-associated nosocomial infection rates. Case definitions for the infection types are listed in table 1. The data for this objective are not nationally representative because the NNIS is based on a non-random sample of 82 hospitals that volunteered to participate. Surgical wound infection rates are also measured by NNIS; they are reported as infections per 100 operations for four risk categories based on an index established by Culver, et al.: low risk, medium-low risk, medium-high risk, and high risk (10) . This article details the derivation of the surgical wound infection rate and explains the patient risk categories. Methods used to calculate this measure are also covered in the NNIS manual (9).
Objective 20.6: Illness among international travelers
Illness among international travelers is measured as the number of reported cases compiled from specific surveillance systems. Hepatitis A for objective 20.6 is reported as the number of cases, not cases per 100,000 population as in objective 20.3. The base numbers are obtained from the National Notifiable Disease Surveillance System (NNDSS); the proportion attributed to travelers is obtained from the Viral Hepatitis Surveillance Program (VHSP); the result is multiplied by 3.0 to adjust for underreporting. An international traveler is defined by the VHSP as a person with an identified case who traveled outside the U.S. or Canada to an area highly endemic for hepatitis A 2-6 weeks prior to onset of illness. Malaria data are obtained from the Malaria Surveillance System (MSS), and typhoid data from the Typhoid Surveillance System (TSS). Case definitions are listed in table 1.
Objective 20.7: Bacterial meningitis
To measure objective 20.7, the number of cases involving the isolated pathogenic agents of bacterial meningitis-H. During the past 12 months, how many times has (child) had diarrhea severe enough the (he/she) had to cut down on more than a half a day on things that (he/she) usually does?
During the past twelve months, did (child) ever receive child care in a place that cares for more than 6 children? This includes day care centers, pre-school, nursery school, religious school, kindergarten, but does not include child care that is provided in this home.
In how many of the past 12 months did (child) receive such child care? (see table 2 for survey questions) and are reported as a percent. The measure for this objective is the population-weighted number of children who were reported as having experienced a case of diarrhea in the past year that made the child cut down on the things he/she does for at least half of a day (numerator) among all those reported as having received child care outside of the home in a setting that contained at least six children at any time during the past year (denominator).
Objective 20.9: Ear infections among children in child care centers
Objective 20.9 is measured by the number of restricted activity days per 100 people for children 4 years of age and under. This measure has been taken directly from the NHIS core questionnaire. The number of restricted activity days for children under 5 years old is the total number of bed days (i.e., the person stays in bed for more than half the day) and cut-down days (i.e., the person cuts down more than half of a day on things he/she usually does) attributed to ear infections and is divided by the total number of children in that age group. The procedures and technical notes regarding the calculations of this measure are published annually in Current Estimates from the National Health Interview Survey (13) . These data will not be available after 1996.
Objective 20.10: Pneumonia-related illness
The measure for this objective is given in terms of the number of restricted activity days due to pneumonia per 100 people. The total number of restricted activity days for adults 65 years and over is the sum of the number of bed days (i.e., the person stays in bed for more than half the day), work-loss days (i.e., the person 18 years and over misses at least half of a day from a job or business) and cut-down days (i.e., the person cuts down more than half of a day on things he/she usually does) attributed to pneumonia-related illnesses for persons 65 years and over (13) . For children 4 years of age and under, the total number of bed days and cut-down days attributed to pneumonia-related illness are aggregated. The denominators are the total number of persons 65 years and over for the adult measure and 4 years and under for the child measure. The procedures and technical notes regarding the calculations of these measures are published annually in Current Estimates from the National Health Interview Survey (13) . These data will not be available after 1996.
20.11: Immunization
Immunization is measured in categories based on age, risk, and specific vaccination regimen. The percent immunized in children 2 years of age and under is measured in terms of the proportion who received the complete schedule of the basic immunization series (four doses of diphtheria-tetanus-pertussis, three oral live polio, and one measles-mumps-rubella), as well as recommended doses of specific antigens (Haemophilus Influenzae type b conjugate, hepatitis B virus, and varicella zoster virus) as reported on the NHIS.
In 1995 the objective was modified to track children 19-35 months of age. The revised age range allows comparability with the National Immunization Survey (see table 3 for survey questions) which collects State-level data and complements the NHIS. Immunization is also measured according to involvement of children in specific institutions: by the proportion immunized in licensed child care facilities and by the proportion immunized who are enrolled in kindergarten through post-secondary education institutions. The measure is a range of immunization levels for specific antigens. To obtain a complete explanation of calculations of childhood immunization levels, contact the National Immunization Program (NIP) technical service at (404) 639-8235. Other measures being monitored are the pneumococcal and influenza immunizations in non-institutionalized chronically ill people or people 65 years and over, as well as high-risk populations. These measures are obtained directly from NHIS (see table 4 for survey questions). Between 1986 and 1994 there have been no sources of data to measure immunization levels among the institutionalized chronically ill or institutionalized persons 65 years and over. In 1995 NCHS conducted a National Nursing Home Survey (NNHS) that will be repeated every other year. This survey includes questions about influenza and pneumococcal vaccination in nursing home residents (table 5) .
Hepatitis B immunization among infants of antigen-positive mothers is measured as the percent of Table 5 . National Nursing Home Survey pneumonia and influenza vaccination questions During the past 12 months, has (patient) had a flu shot at this facility or any other location?
Has (patient) EVER has a pneumococcal vaccine, that is, pneumonia vaccination?
Source: National Nursing Home Survey, National Center for Health Statistics, CDC.
infants in this category who receive three doses of the vaccine. The data are estimated based on public sector data reported from local health departments, which represent about 50 percent of the cohort. Data for occupationally-exposed workers are from random sample surveys of approximately 3,000 hospital employee vaccination records. These surveys are completed every 2-3 years by the Hepatitis Branch, Division of Viral and Rickettsial Diseases, NCID, CDC, and cover approximately two-thirds of occupationally-exposed workers. Hepatitis B immunization baseline data for men who have sex with men are from an analysis of serologic data from a local survey in San Francisco (14) ; there are no national estimates for this high-risk group. At time of publication, there are no data sources to monitor hepatitis B immunizations among injecting drug users.
20.12: Postexposure rabies treatments
Two indirect methods are used to produce a range of estimated numbers of postexposure prophylaxis treatments for rabies. The lower end of the range extrapolates annual numbers of treatments by applying the treatment incidence rates calculated for participating States during an earlier study performed by Helmick (15) to annual U.S. Census population estimates, adjusted to reflect current preponderant State animal rabies reservoirs. The high end of the range utilizes sales data for rabies immune globulin furnished by rabies vaccine manufacturers (Rabies Vaccine and Immune Globulin Manufacturers Sales Data), which reflect the amount purchased, not the amount used in treatments. Because the amount of rabies immune globulin used is based on body weight, the number of treatments calculated using this method is based on an assumed average body weight. The estimates generated by these two methods represent both an underestimate and an overestimate of the actual number of treatments. For more information regarding this measure, contact Jeannie Walsh at NCID, (404) 639-2762.
20.13: Immunization Laws
The measures used to track objective 20.13 are based on the antigen (diphtheria toxoid, tetanus toxoid, pertussis vaccine, measles vaccine, mumps vaccine, rubella vaccine, polio vaccine, haemophilus vaccine, and hepatitis B vaccine) and the type of facility (schools (K-12) and day care centers). Data are obtained from the Survey on Immunization Laws (SIL). The 1989 baseline was established as a single measure, but subsequent measures have been ranges, based on whether or not the law mandates immunization at preschool and/or kindergarten level and above, and based on which antigens are specified in the law. The measures are reported as the number of States with a particular attribute of the law.
20.14: Provision of immunization by clinicians
Provision of immunizations is measured by the proportion of clinicians who routinely provide services to 81-100 percent of their patients in each of the different clinician categories: pediatricians, nurse practitioners, and family physicians for services provided to children; nurse practitioners, obstetricians/gynecologists, internists, and family physicians for services provided to adults. The data were collected in the 1992 Primary Care Provider Surveys (PCPS). Five primary care provider professional associations participated in the 1992 PCPS by mailing the survey to their members who were randomly selected to participate. These associations also compiled and analyzed the data. Data were collected for children (DTP vaccination, oral polio vaccination, tetanus-diphtheria booster, and Hib vaccination) and adults (tetanus-diphtheria booster, influenza vaccination, and pneumococcal vaccination).
Further discussion on collection procedures, interpretation of data, lists of survey questions, and discussion of the results of this survey can be obtained by contacting the Office of Disease Prevention and Health Promotion (16) . Because the data are derived from five independently administered surveys, the results of this survey cannot be combined to create one measure for this objective. The survey is planned to be re-administered in 1997.
20.15: Financial barriers to immunization
Financial barriers to immunization are measured by the percent of employer-based insurance plans that provide coverage for immunizations. The plans that are included are conventional insurance plans, preferred provider organizations, and health maintenance organizations. The data were collected by the Health Insurance Association of America (HIAA) Employer Survey and each plan was measured separately. HIAA has no plans to re-administer the survey at this time. Objective 20.16 is measured in terms of the percent of public health departments that provide immunizations. The baseline data for this objective were collected in 1990 by Immunization Grant Program Profiles (IGPP). Follow-up data are from the 1992-1993 National Profile of Local Health Departments, a survey conducted by the National Association of County and City Health Officials (NACCHO). The latest measure is a range based on the percent of local health departments (LHDs) that provide adult immunizations such as influenza, tetanus, diphtheria, hepatitis B, or pneumococcal disease within 12 months prior to completing the survey (17) . According to this study, an LHD is defined as an administrative or service unit of local or state government concerned with health and carrying some responsibility for the health of a jurisdiction smaller than the State. A total of 2,079 LHDs meeting the study definition of an LHD completed the survey instrument, with an overall response rate of 72 percent. Because the information provided in this study came from 1992 data for some LHDs and 1993 data for others, the study is dated as 1992-93. However, the data from each LHD reflects a 1-year time period only. The findings of this study have been published by NACCHO in their report, 1992-1993 National Profile of Local Health Departments (17) . The next survey to be administered by NACCHO is in 1996.
20.16: Public health department provision of immunizations

20.17: Local health programs to identify tuberculosis
The measure for monitoring LHDs with ongoing programs geared to identify TB and latent infections in highrisk populations is the percent of departments with such programs among all LHDs. This measure was determined in a survey that assessed the total number of LHDs that reported tuberculosis services as a service provided directly or indirectly through contractual arrangement (17) . The data for this objective were obtained from the 1992-93 National Profile of Local Health Departments (see description in discussion of objective 20.16 ). This objective is not likely to be monitored in this format in the future. Most tuberculosis screening is done to identify persons with latent infection who may be candidates for preventive therapy. Much of this screening is done in settings outside of the health departments (for example, hospitals or prisons). CDC is developing systems to assist LHDs assess the outcomes of screening programs in their communities.
20.18: Preventive therapy for tuberculosis
To monitor successful completion of preventive therapy for tuberculosis-infected individuals, the percent of persons who started on such therapy who complete the therapy is used. This number is a compilation of State and selected metropolitan area data that are submitted to the Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, CDC, which compiles the data and summarizes them in the Tuberculosis Program Management Report Series (18) . States submit Tuberculosis Program Management Report forms which report aggregate data on the number of persons starting preventive therapy and the subsequent number of persons completing therapy. The number of persons starting therapy include those who are contacts to TB cases, recent tuberculin skin test converters, and others with tuberculous infection. Completion is determined by the number of people who started therapy and have completed taking the prescribed medication for the full six months, or those who, by a physician's determination, received an adequate course of therapy in less than six months. There is variability in the number of States that participate as well as in the percent of TB cases that are being reported. Objective 20.19 NOTE: Epidemic-related pneumonia and influenza deaths are those that occur above and beyond the normal yearly fluctuations of mortality. Because of the extreme variability in epidemic-related deaths from year to year, the it will be measured using a 3-year average. Basic immunization series among children under age 2: at least 90 percent.
20.19: Laboratory capability for influenza diagnosis
Basic immunization series among children in licensed child care facilities and kindergarten through post-secondary education institutions: at least 95 percent.
Hepatitis B immunization among high-risk populations, including infants of hepatitis B surface antigen-positive mothers 13 to at least 90 percent; occupationally exposed workers to at least 90 percent; injecting drug users in drug treatment programs to at least 50 percent; and men who have sex with men to at least 50 percent.
Pneumococcal pneumonia and influenza immunization among institutionalized chronically ill or older people: at least 80 percent. 
